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Abstract Gastric cancer is the second leading cause of cancer-
related deaths worldwide and it seems that environmental and
lifestyle factors and infection withHelicobacter pylori (H.pylori)
have had a major role in the etiology of gastric cancer. The aim
of this study was to investigate the presence ofH. pyloriDNA in
archival gastric tissues of patients with gastric cancer disease by
rapid, sensitive and specific technique of Scorpion Realtime
PCR. This retrospective cross-sectional study was performed
on 285 paraffin embedded gastric specimens of patients who
were pathologically proved for gastric cancer admitted in Bou-
Ali, Shahid Rajaie and Dehkhoda hospitals and Bahar and
Farzam private laboratory in Qazvin city in Iran during 2009
and 150 paraffin embedded pathological specimens of patients
with other proved diagnosis other than gastric cancer. Results of
our Scorpion Realtime PCR analysis showed that DNA of H.
pylori DNA was present in 78.42 % of our total specimens.
Modified McMullen’s Staining of paraffin embedded sections
was positive in 210 patients. Also we were not able to finding
significant relationship between demographic characteristics of
our studied patients and presence of H. pylori DNA in their
formaldehyde fixed paraffin embedded gastric tissues samples.
Existence of H. pylori in gastric tissue samples of patients with
gastric cancer is controversial and our results indicated that in our
studied specimens prevalence ofH.pyloriwas significantly more
than recent published reports.
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Introduction
Gastric cancer is the second leading cause of cancer-related
deaths worldwide. International Agency for Research on
Cancer reported that in Asia malignancy of the stomach is
the most common cancer and nearly two-thirds of it occurs in
developing countries [1]. Although the incidence and mortal-
ity of distal gastric cancers has decreased in the Western
world, the incidence of proximal tumors is increasing in the
male population of those regions. In contrast, in Asian conti-
nent distal tumors have increased while proximal tumors have
decreased [2]. This geographic variation accompanying with
differences in lifestyle, time trends and migratory effects
associated with the incidence of gastric cancer suggest that
environmental and lifestyle factors have a major role in the
etiology of gastric cancer [3, 4].
Gastric cancer is an outcome of a complex interaction
between host and environmental factors and H. pylori infec-
tion. Scientific evidence suggests the importance of host fac-
tors and microbial agents in pathogenesis of cancer [5, 6].
Helicobacter pylori (H. pylori) are Gram-negative, micro-
aerophil and spiral-shaped bacteria. H. pylori infection affects
50 % of the population, worldwide [7]. H. pylori infection
initiate an inflammatory response which is influenced by
genetic polymorphisms which in turn can either accentuate
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or attenuate the host’s response to inflammation and affecting
the interaction’s outcome. Recent advances in the study of the
etiological backgrounds of non-cardia gastric adenocarcinoma
revealed that H. pylori infection is an established important
causal factor for this kind of cancer.
In the process of gastric carcinogenesis, bacterial virulence
factors that have been implicated include the cytotoxin-
associated gene A antigen (Cag A), vacuolating cytotoxin
(VacA), and outer membrane proteins (OMP) [8]. The cagE
genotype has been associated with gastric cancer in some
studies, but contrary results have also been published [9, 10].
On the basis of these differences of opinion about the
prevalence of H. pylori association with gastric cancer exists
in the literature [11–17] we planned this study to determine the
overall prevalence of H. pylori DNA in gastric carcinoma.
Materials and Methods
Patients and Methods This retrospective cross-sectional
study was performed on 285 paraffin embedded gastric speci-
mens of patients who were pathologically proved for gastric
cancer admitted in Bou-Ali, Shahid Rajaie and Dehkhoda hos-
pitals and Bahar and Farzam private laboratory in Qazvin city in
Iran during 2009. Ethical Committee of Qazvin University of
Medical Sciences approved our study. Control samples were 150
paraffin embedded pathological specimens of patients with other
proved diagnosis other than gastric cancer.
Clinical Samples Initially, the paraffin embedded gastric tis-
sues were sectioned into 50 μm slices followed by DNA extrac-
tion using DNA preparation protocol obtained from Section of
Cancer Genomics, Genetics Branch, NCI, Institute of Health.
Modified McMullen’s Staining of Gastric Biopsy The paraf-
fin embedded sections was dewaxed, dehydrated and cov-
ered by carbol-fuchsin for 2 min. The sections rinsed and
stained malachite green for 2 min. Then slides rinsed in tap
water, air dried and observed under the light microscope.
Magenta color particles are indicative of H. pylori.
Scorpion Real-Time Scorpion real-time PCR was performed
using ABI Prism 7500 Sequence Detection System (Applied
Biosystem, USA). The tails of the Scorpion primers were
designed as previously described byBurucoa [18]. All primers
and probes used were synthesized by Metabion company
(Germany) (Table 1). The total volume of the real-time PCR
was 20 μl containing 5 μl of DNA from a clinical sample or
bacterial isolate, 0.1 μMof oligonucleotide primer 23SF2 and
0.08 μM of 23SScWT, while the total volume of 20 μl was
achieved by addition of distilled water. The cycling conditions
were adjusted in a way suitable to be used by ABI Prism 7500
Sequence Detection System (Applied Biosystem, USA) with
an initial denaturation at 95 °C for 45 s, 50 cycles at 95 °C for
15 s, 55 °C for 34 s, and 72 °C for 20 s. The acquisition of a
signal was performed at 57 °C during each cycle. A negative
control for Scorpion real-time PCR obtained by observation of
no amplification signal except internal amplification by
adding DDW instead of DNA to the prepared real-time PCR
master mix. A positive control for Scorpion PCR was consti-
tuted by using extracted DNA from H. pylori ATCC 26695.
Positive extraction control was performed for each biopsy
specimen in a separate tube in a final volume of 25 μl with
Premix Ex Taq (TaKaRa, Shiga, Japan), 5 μl of extracted
DNA from biopsy specimen, 0.25 μM of BGLO1 and
BGLO2 primers, and 0.5× Sybergreen 1 (Sigma Aldrich)
and on the basis of the results of this test, 285 of the collected
biopsies were entered in our study. The cycling program was
1 cycle at 95 °C for 10 s and 40 cycles of 95 °C for 5 s, 55 °C
for 34 s, and 72 °C for 10 s.
Statistical Analysis Data were analyzed using SPSS11.5
software with 95 % confidence intervals (95 % CI).
Results
In this survey the prevalence of H. pylori infection in gastric
samples of patients with gastric cancer was determined using
the data obtained by:
Detection of H pylori by Scorpion Real-Time PCR:
Initially, Scorpion real-time PCR was performed on H.
pylori ATCC 26695. Of total 285 samples, 224 biopsies
found to be positive for H. pylori by Scorpion real-time
PCR (78.49 %) whereas 61 samples showed negative
results. Among samples with positive Scorpion real-
Table 1 Primers and probes se-
quences for detection of H.pylori
in pathological specimens of
gastric patients and controls
Oligonucleotide Sequence
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time PCR test, 210 samples were also positive with
Modified McMullen’s Staining (93.75 %). From of total
150 control samples 47 biopsies found to be positive for
H. pylori by Scorpion real-time PCR 47 (31.3 %) where-
as 103 samples showed negative results. Among sam-
ples with positive Scorpion real-time PCR test,
40(85.1 %) samples were also positive with Modified
McMullen’s Staining.
Scorpion Real-Time PCR: Scorpion real-time PCR on
DNA extracts of H. pylori ATCC 26695 as control
strains produced expected signals. The standard curve
used to calculate the concentration of H. pylori DNA in
unknown samples is presented in Fig. 1a. The linear
regression coefficient was 0.996 and the efficiency of
PCR 92.054 %. Figure 1b shows the fluorescent curves of
the standard serial dilution from 1×104 to 1×102 copy per
microliter. Electrophoresis pattern of products in scorpion
real-time PCR assay in agarose gel is shown in Fig. 2. A
140 bp fragment in the peptidytransferase gene of 23S
rRNA showed a successful amplification. Of total patients
(285 cases) with gastric cancer who entered the study, 224
cases (78.24 %) were found to haveH. pyloriDNA in their
gastric biopsy specimens by Scorpion real-time PCRmeth-
od. Our study showed that there is no significant associa-
tion between demographic characteristics of our patients,
history of gastric involvement, gastric disease, and the
presence of bacterium. Also we were not able to find any
relationship between the sex, family income, and accom-
modation variables and the colonization of H. pylori in
gastric cancer tissues (data not shown).
Fig. 1 a Standard curve used to calculate the concentration of H.pylori
DNA in unknown samples. The linear regression coefficient is 0.996
and efficiency of PCR is 92.054 %; b Fluorescent curves of the standard
dilution series. From the left to the right 104, 103, 102 and the negative
control is presented by the horizontal curve
8 9
Fig. 2 The Scorpion Realtime PCR products of tested samples. PCR products were electrophoresed in a 2 % agarose gel. Lane 8: Helicobacter pyori
ATCC26695 with a positive 140 bp band; Lane 9:100 bp DNA ladder. Other lines: Scorpion PCR products of samples
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Discussion
H. pylori infects human in childhood and at this time it has
infected one half of the world’s population. It is the only
bacterium which is listed in the microbial agents which are
involved in human cancer diseases.
Our finding showed that from the total of 285 formalde-
hyde fixed paraffin embedded samples of pathologically
proved gastric cancer patients which enterd to our study, 224
patients had H. pylori DNA while Hashemi and colleagues
reported that in their 161 studied normal mocusa specimens of
Iranian population 54 had H.pylori (33.5 %) [19].
The results of published researches in the medical litera-
ture related to the involvement of H. pylori in gastric cancer
is controversial and confirmation of this involvement and
determination of the level of this involvement in different
societies are also important issues.
As H. pylori is a fastidious bacteria, microbiological
methods of culture and identification of these bacteria are
difficult and needs a long time and adequate sensitivity and
specificity of modern molecular methods in diagnosis of
these bacteria make them attractive methods for studying
prevalence of H. pylori in different clinical specimens [6].
Results of our study showed that from total 224 number of
specimens with H.pylori DNA, all had CagA positive geno-
type (Data not shown).
Khanna et al. in a study on 50 proved cases of gastric
cancer found that the prevalence rate ofH. pylori infection in
their patients was lower than in the control population,
suggesting that H. pylori may not be responsible for gastric
carcinogenesis in this population [16]. In other study Rudi
and colleagues in their study on the sera of 111 Caucasian
patients with histologically confirmed gastric cancer found
that their data do not provide evidence that the contribution
of H. pylori infection to the carcinogenesis of gastric cancer
is of major significance at least in a population with low
gastric cancer rates and with high socioeconomic status [17].
On the other hand Babus and colleagues in a study on
analysis of 12 prospective case—control studies concluded that
between about 65 % and 80 % of non-cardia gastric cancers
were attributable to H. pylori infection [13, 19]. Uemura et al.
studied 1,526 Japanese patients, of whom 1,246 had H. pylori
infection and 280 were not infected. Over a mean follow-up
period of 7.8 years, gastric cancer developed in 2.9% of patients
with H. pylori infection and none of the uninfected patients
developed gastric cancer, giving a relative risk of 34.5 [14].
Martínez and colleague in a case-control study including 46
gastric cancer cases and 99 controls with non-atrophic gastritis
from a high risk zone for gastric cancer showed that there is a
positive association between Helicobacter pylori CagA posi-
tive strains with non-cardial gastric cancer etiology [15].
Although we studied a relatively large population and we
used sensitive and specific method of scorpion real time PCR
assay, our results indicated that in our studied specimens
prevalence of H.pylori was many times more than recent
published reports [20, 21] and is in consistent with the latter
studies indicating a possible role for H. pylori in gastric
cancer and observed higher rate of prevalence of these bac-
teria in our patients, may lay back in the polymorphism and
genetic diversity of isolated H.pylori strains which influence
the oncogenic potential of these bacteria [22]
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